DISPOSITION OF ORAL METHOTREXATE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AND ITS RELATION TO 6-MERCAPTOPURINE PHARMACOKINETICS

被引：0
|
作者：
KOREN, G
SOLH, H
KLEIN, J
SOLDIN, SJ
GREENBERG, M
机构：
[1] UNIV TORONTO,HOSP SICK CHILDREN,DIV HEMATOL ONCOL,TORONTO M5G 1X8,ONTARIO,CANADA
[2] UNIV TORONTO,HOSP SICK CHILDREN,DEPT PEDIAT,TORONTO M5G 1X8,ONTARIO,CANADA
[3] UNIV TORONTO,HOSP SICK CHILDREN,DEPT BIOCHEM,TORONTO M5G 1X8,ONTARIO,CANADA
[4] UNIV TORONTO,HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA
[5] UNIV TORONTO,HOSP SICK CHILDREN,DEPT PHARMACOL,TORONTO M5G 1X8,ONTARIO,CANADA
来源：
MEDICAL AND PEDIATRIC ONCOLOGY | 1989年 / 17卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：450 / 454
页数：5
相关论文
共 50 条
  • [21] Adherence to 6-Mercaptopurine in children and adolescents with Acute Lymphoblastic Leukemia
    Alsous, Mervat
    Abu Farha, Rana
    Alefishat, Eman
    Al Omar, Suha
    Momani, Deema
    Gharabli, Alia
    McElnay, James
    Horne, Robert
    Rihani, Rawad
    PLOS ONE, 2017, 12 (09):
  • [22] PHARMACOKINETIC DETERMINANTS OF 6-MERCAPTOPURINE, MYELOTOXICITY AND THERAPEUTIC FAILURE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    WHALEN, CE
    SOLDIN, SJ
    SULH, H
    KOREN, G
    GREENBERG, M
    CLINICAL CHEMISTRY, 1986, 32 (06) : 1092 - 1092
  • [23] PHARMACOKINETICS OF METHOTREXATE GIVEN INTRATHECALLY TO CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    SKIBINSKA, L
    DASZKIEWICZ, P
    MICHALEWSKA, D
    RADWANSKA, U
    POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY, 1988, 40 (02): : 135 - 143
  • [24] GENETIC-VARIATION IN RESPONSE TO 6-MERCAPTOPURINE FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    LENNARD, L
    LILLEYMAN, JS
    VANLOON, J
    WEINSHILBOUM, RM
    LANCET, 1990, 336 (8709): : 225 - 229
  • [25] PROGNOSTIC-SIGNIFICANCE OF METHOTREXATE AND 6-MERCAPTOPURINE DOSAGE DURING MAINTENANCE CHEMOTHERAPY FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    SCHMIEGELOW, K
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1991, 8 (04) : 301 - 312
  • [26] PHARMACOKINETIC DETERMINANTS OF 6-MERCAPTOPURINE (6 MP) MYELOTOXICITY AND THERAPEUTIC FAILURES IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    KOREN, G
    SULH, H
    WHALEN, C
    SOLDIN, S
    ZIPURSKY, A
    GREENBERG, M
    PEDIATRIC RESEARCH, 1986, 20 (04) : A205 - A205
  • [27] Maintenance chemotherapy of acute lymphoblastic leukemia in children - Clinical and pharmacological aspects of the monitoring and adjustment of oral methotrexate and 6-mercaptopurine dosage
    Schmiegelow, K
    DANISH MEDICAL BULLETIN, 1998, 45 (05) : 510 - 532
  • [28] Comparative pharmacokinetics of oral 6-mercaptopurine and intravenous 6-mercaptopurine riboside in children
    Mawatari, H
    Unei, K
    Nishimura, S
    Sakura, N
    Ueda, K
    PEDIATRICS INTERNATIONAL, 2001, 43 (06) : 673 - 677
  • [29] Language, 6-mercaptopurine adherence, and relapse in children with acute lymphoblastic leukemia
    Robles, Joanna
    Chen, Yanjun
    Hageman, Lindsey
    Aristizabal, Paula
    Landier, Wendy
    Bhatia, Smita
    Wadhwa, Aman
    JNCI CANCER SPECTRUM, 2024, 8 (05)
  • [30] DISTURBANCE OF 6-MERCAPTOPURINE METABOLISM BY COTRIMOXAZOLE IN CHILDHOOD LYMPHOBLASTIC-LEUKEMIA
    REES, CA
    LENNARD, L
    LILLEYMAN, JS
    MADDOCKS, JL
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 12 (02) : 87 - 89
12345